Karafin MS - Search Results

1

Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.

Francis RO, Mahajan S, Rapido F, La Carpia F, Soffing M, Divgi C, Yeh R, Mintz A, Leslie L, Agrest I, Karafin MS, Ginzburg Y, Shaz BH, Spitalnik SL, Schwartz J, Thomas T, Fu X, Amireault P, Buffet P, Zimring JC, D'Alessandro A, Hod EA. Francis RO, et al. Among authors: karafin ms. Transfusion. 2019 Jul;59(7):2264-2275. doi: 10.1111/trf.15310. Epub 2019 Apr 19. Transfusion. 2019. PMID: 31002399

2

The impact of apheresis platelet manipulation on corrected count increment.

Karafin M, Fuller AK, Savage WJ, King KE, Ness PM, Tobian AA. Karafin M, et al. Transfusion. 2012 Jun;52(6):1221-7. doi: 10.1111/j.1537-2995.2011.03476.x. Epub 2012 Jan 10. Transfusion. 2012. PMID: 22233358 Free PMC article.

3

Transfusion medicine education: an integral foundation of effective blood management.

Karafin MS, Bryant BJ. Karafin MS, et al. Transfusion. 2014 May;54(5):1208-11. doi: 10.1111/trf.12658. Transfusion. 2014. PMID: 24819073 No abstract available.

4

The future of red blood cell alloimmunization risk reduction.

Karafin MS, Denomme GA, Bryant BJ. Karafin MS, et al. Transfusion. 2015 Jan;55(1):220-1. doi: 10.1111/trf.12863. Transfusion. 2015. PMID: 25582238 No abstract available.

5

Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Karafin MS, Field JJ, Gottschall JL, Denomme GA. Karafin MS, et al. Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9. Transfusion. 2015. PMID: 25757390

6

Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States.

Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ. Karafin MS, et al. Transfus Apher Sci. 2016 Feb;54(1):158-62. doi: 10.1016/j.transci.2015.12.001. Epub 2015 Dec 23. Transfus Apher Sci. 2016. PMID: 26775259

7

Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.

Irani MS, Karafin MS, Ernster L. Irani MS, et al. Among authors: karafin ms. J Clin Apher. 2017 Feb;32(1):59-61. doi: 10.1002/jca.21461. Epub 2016 Apr 26. J Clin Apher. 2017. PMID: 27112240

8

Phosphatidylethanolamine is progressively exposed in RBCs during storage.

Larson MC, Karafin MS, Hillery CA, Hogg N. Larson MC, et al. Among authors: karafin ms. Transfus Med. 2017 Apr;27(2):136-141. doi: 10.1111/tme.12382. Epub 2017 Jan 30. Transfus Med. 2017. PMID: 28134466 Free PMC article.

9

Trends in US minority red blood cell unit donations.

Yazer MH, Delaney M, Germain M, Karafin MS, Sayers M, Vassallo R, Ziman A, Shaz B; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Yazer MH, et al. Among authors: karafin ms. Transfusion. 2017 May;57(5):1226-1234. doi: 10.1111/trf.14039. Epub 2017 Feb 16. Transfusion. 2017. PMID: 28205236

10

Patient factors associated with unidentified reactivity in solid-phase and polyethylene glycol antibody detection methods.

Miller NM, Johnson ST, Carpenter E, Naczek CA, Karafin MS. Miller NM, et al. Among authors: karafin ms. Transfusion. 2017 May;57(5):1288-1293. doi: 10.1111/trf.14079. Epub 2017 Mar 14. Transfusion. 2017. PMID: 28294343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters